News
EluPro™ Q2 revenue up 49% sequentially; Elutia advances next-generation drug-eluting biomatrix for breast reconstruction Conference call today at 5:00 p.m. ET / 2:00 p.m. PT GAITHERSBURG, Md., Aug. 14 ...
We ditched static dashboards for a live, AI-driven control tower that predicts issues and guides smarter decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback